These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29317115)

  • 41. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
    Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
    Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation.
    Schewel D; Frerker C; Schewel J; Wohlmuth P; Meincke F; Thielsen T; Kreidel F; Kuck KH; Schäfer U
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):502-14. PubMed ID: 24259366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between plasma N-terminal pro-brain natriuretic peptide levels and changes in New York Heart Association functional class, left atrial size, left ventricular size and function after mitral and/or aortic valve replacement.
    Elasfar A
    Ann Saudi Med; 2012; 32(5):469-72. PubMed ID: 22871614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-operative N-terminal pro-brain natriuretic peptide predicts in-hospital mortality after living donor liver transplantation.
    Canbolat İP; Akdeniz C; Ferah O; Tokat Y
    Turk Kardiyol Dern Ars; 2020 Jun; 48(4):374-379. PubMed ID: 32519985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement.
    Anantha-Narayanan M; Malik U; Mbai M; Megaly M; Florea V; Sharma A; Cavalcante JL; Garcia S
    Catheter Cardiovasc Interv; 2020 Apr; 95(5):1034-1041. PubMed ID: 31419009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis.
    Weber M; Hausen M; Arnold R; Nef H; Moellman H; Berkowitsch A; Elsaesser A; Brandt R; Mitrovic V; Hamm C
    Heart; 2006 Nov; 92(11):1639-44. PubMed ID: 16740919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interaction of forced expiratory volume in 1 s and N-terminal pro-B-type natriuretic peptide with outcomes after transcatheter aortic valve replacement.
    Crestanello JA; Greason KL; Mathew J; Eleid MF; Nkomo VT; Rihal CS; Bagameri G; Holmes DR; Pislaru SV; Sandhu GS; Lee AT; King KS; Alkhouli M
    Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 36645236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Value of N-Terminal Pro-form B-Type Natriuretic Peptide in Patients With Moderate Aortic Stenosis.
    Ito S; Miranda WR; Jaffe AS; Oh JK
    Am J Cardiol; 2020 May; 125(10):1566-1570. PubMed ID: 32204871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute Heart Failure at the Time of Transcatheter Aortic Valve Replacement Does Not Increase Mortality.
    Burke WT; Trivedi JR; Flaherty MP; Grubb KJ
    Innovations (Phila); 2018; 13(1):47-50. PubMed ID: 29462050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
    Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
    Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin.
    Lábr K; Špinar J; Pařenica J; Špinarová L; Málek F; Špinarová M; Ludka O; Jarkovský J; Benešová K; Goldbergová-Pávková M; Lábrová R
    Kidney Blood Press Res; 2018; 43(6):1865-1877. PubMed ID: 30537724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-Procedural N-Terminal Pro-B Type Natriuretic Peptide Predicts Contrast-Induced Acute Kidney Injury and Long-Term Outcome in Elderly Patients After Elective Percutaneous Coronary Intervention.
    Lin KY; Wu ZY; You ZB; Zheng WP; Lin CJ; Jiang H; Ruan JM; Guo YS; Zhu PL
    Int Heart J; 2018 Sep; 59(5):926-934. PubMed ID: 30158378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) in severe aortic valve stenosis: association with outcome after transcatheter aortic valve implantation (TAVI).
    Baldenhofer G; Laule M; Mockel M; Sanad W; Knebel F; Dreger H; Leonhardt F; Sander M; Grubitzsch H; Baumann G; Stangl K; Stangl V
    Clin Chem Lab Med; 2017 Feb; 55(2):275-283. PubMed ID: 27522619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism.
    Lankeit M; Jiménez D; Kostrubiec M; Dellas C; Kuhnert K; Hasenfuß G; Pruszczyk P; Konstantinides S
    Eur Respir J; 2014 Jun; 43(6):1669-77. PubMed ID: 24627529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients.
    Schachner T; Wiedemann D; Fetz H; Laufer G; Kocher A; Bonaros N
    Clinics (Sao Paulo); 2010; 65(12):1239-45. PubMed ID: 21340210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-terminal pro-Brain natriuretic peptide as a useful biomarker for monitoring prognosis in patients with cardiac valve replacement.
    Cai B; Wang L; Liu J; Shi Y; Guo Y
    J Clin Lab Anal; 2011; 25(3):149-55. PubMed ID: 21567460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.